Immatics NV (IMTX)
6.73
-0.41
(-5.74%)
USD |
NASDAQ |
Oct 16, 16:00
6.71
-0.02
(-0.30%)
After-Hours: 20:00
Immatics Cash from Investing (Quarterly) : -9.277M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.277M |
| March 31, 2026 | -32.86M |
| December 31, 2025 | -34.76M |
| September 30, 2025 | 147.24M |
| June 30, 2025 | 76.61M |
| March 31, 2025 | 49.26M |
| December 31, 2024 | -47.22M |
| September 30, 2024 | 69.84M |
| June 30, 2024 | 77.29M |
| March 31, 2024 | -262.46M |
| December 31, 2023 | 65.37M |
| September 30, 2023 | -76.76M |
| June 30, 2023 | -18.38M |
| March 31, 2023 | -3.990M |
| December 31, 2022 |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | -58.19M |
| March 31, 2022 | 6.547M |
| December 31, 2021 | -2.422M |
| September 30, 2021 | 23.41M |
| June 30, 2021 | -15.50M |
| March 31, 2021 | 3.082M |
| December 31, 2020 | -0.8382M |
| September 30, 2020 | -13.15M |
| June 30, 2020 | -2.381M |
| March 31, 2020 | -2.630M |
| December 31, 2019 | -15.41M |
| September 30, 2019 | 14.30M |
| June 30, 2019 | -0.8736M |
| March 31, 2019 | -0.3781M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioNTech SE | -118.82M |
| MediGene AG | -- |
| InflaRx NV | 14.90M |
| Twist Bioscience Corp. | -10.20M |
| Prime Medicine, Inc. | 24.03M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -70.00M |
| Cash from Financing (Quarterly) | -0.9257M |
| Free Cash Flow | -246.23M |
| Free Cash Flow Per Share (Quarterly) | -0.5195 |
| Free Cash Flow to Equity (Quarterly) | -70.32M |
| Free Cash Flow to Firm (Quarterly) | -70.77M |
| Free Cash Flow Yield | -28.20% |